ANIP
NASDAQ HealthcareANI Pharmaceuticals, Inc. - Common Stock
Drug Manufacturers - Specialty & Generic
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
๐ Market Data
| Price | $80.39 |
|---|---|
| Volume | 224,468 |
| Market Cap | 1.83B |
| Beta | 0.430 |
| RSI (14-Day) | 56.2 |
| 200-Day MA | $82.68 |
| 50-Day MA | $76.49 |
| 52-Week High | $99.50 |
| 52-Week Low | $56.71 |
| P/E Ratio | 24.21 |
| Forward P/E | 7.59 |
| Price / Book | 3.12 |
๐ฏ Investment Strategy Scores
ANIP scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ช Falling Knife (57/100) โ this strategy Contrarian plays (oversold + below moving average).
Lowest fit among scored strategies: ๐ Moon Shot (24/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find ANIP in your text
Paste any article, transcript, or post โ the tool will extract ANIP and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.